Gujarat Themis Biosyn Ltd – Bulk Drugs growth momentum

Thanks @T11 – As always super interesting. Just wanted to quickly check on a couple of things:

1. What happens if the GTBL’s customers do not win the tender? How is GTBL sure they will ultimately be beneficiaries of the tender?

2. Any idea on what is the market share of GTBL in Lupin/Optrix for the articular intermediaries?

3. Does LUpin & Optrix buy both the intermediaries or Rifa -s is with Lupin & Rifa-O is with Optrix?

4. By any chance would you also know from whom does Lupin/Optrix competitors procure the intermediaries for the same APIs? Is that costlier/similar price as as what is being provided by GTBL

Thanks for your time.

Regards,
Avinash Baskar